Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-0426 ◽

2020 ◽

Vol 26 (14) ◽

pp. 3557-3564

Author(s):

Richard D. Kim ◽

Nilofer S. Azad ◽

Michael A. Morse ◽

Elizabeth Poplin ◽

Amit Mahipal ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Chimeric Monoclonal Antibody ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

PEAK: A randomized phase II study to compare the efficacy of panitumumab plus mFOLFOX6 to bevacizumab plus mFOLFOX6 in patients (pts) with previously untreated, unresectable metastatic colorectal cancer (mCRC) expressing wild-type KRAS.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps189 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS189-TPS189

Author(s):

L. S. Schwartzberg ◽

V. J. Wagner

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type ◽

Randomized Phase Ii ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

Phase II Study Of S-1, Oral Leucovorin, Oxaliplatin and Bevacizumab Combination Therapy (SOL + BV; SOLA) in Patients with Unresectable Metastatic Colorectal Cancer (MCRC)

Annals of Oncology ◽

10.1016/s0923-7534(20)32377-2 ◽

2012 ◽

Vol 23 ◽

pp. xi131

Author(s):

Y. Miyata ◽

T. Nishina ◽

T. Kato ◽

K. Yamazaki ◽

T. Yoshino ◽

...

Keyword(s):

Colorectal Cancer ◽

Combination Therapy ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

469P Efficacy and safety of anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer - A single-arm, multi-center, phase II study (ALTER-C-002 trial)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.580 ◽

2020 ◽

Vol 31 ◽

pp. S440

Author(s):

K. Ding ◽

Y. Liu ◽

J. Chen ◽

J. Ying ◽

Q. Xu ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Efficacy And Safety ◽

Wild Type ◽

First Line Treatment ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis

Annals of Oncology ◽

10.1093/annonc/mdy149.021 ◽

2018 ◽

Vol 29 ◽

pp. v108 ◽

Author(s):

K. Lesniewski-Kmak ◽

V. Moiseenko ◽

M. Saunders ◽

H. Wasan ◽

G. Argiles ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Intensive Therapy ◽

Primary Analysis ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial

10.1186/1471-2407-12-108 ◽

2012 ◽

Vol 12 (1) ◽

Author(s):

Anne Katrin Berger ◽

Carl von Gall ◽

Ulrich Abel ◽

Stefan Delorme ◽

Matthias Kloor ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Response Monitoring ◽

18Fdg Pet ◽

Download Full-text

A phase 2 study of NEO-102 (ensituximab), a novel chimeric monoclonal antibody, in adult patients (pts) with unresectable, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.3080 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 3080-3080

Author(s):

Richard D. Kim ◽

Nilofer Saba Azad ◽

Michael Morse ◽

Benjamin R. Tan ◽

Elizabeth Poplin ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Metastatic Colorectal Cancer ◽

Adult Patients ◽

Phase 2 ◽

Chimeric Monoclonal Antibody ◽

Phase 2 Study ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2825-5 ◽

2015 ◽

Vol 76 (3) ◽

pp. 547-553 ◽

Author(s):

Tomohiro Nishina ◽

Takeshi Kato ◽

Kentaro Yamazaki ◽

Takayuki Yoshino ◽

Yoshinori Miyata ◽

...

Keyword(s):

Colorectal Cancer ◽

Combination Therapy ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

10.1186/s12885-020-07169-6 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Carlotta Antoniotti ◽

Beatrice Borelli ◽

Daniele Rossini ◽

Filippo Pietrantonio ◽

Federica Morano ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Initial Therapy ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

Multicenter Phase II Study of FOLFOX6 for Previously Untreated Unresectable Metastatic Colorectal Cancer

Journal of Integrative Oncology ◽

10.4172/2329-6771.1000120 ◽

2014 ◽

Vol 03 (02) ◽

Author(s):

Satoru Iwasa

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Multicenter Phase ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text

A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy

Journal of Surgical Oncology ◽

10.1002/jso.20463 ◽

2006 ◽

Vol 93 (5) ◽

pp. 387-393 ◽

Author(s):

Robert C.G. Martin ◽

Charles R. Scoggins ◽

Kelly M. Mc Masters

Keyword(s):

Colorectal Cancer ◽

Radiofrequency Ablation ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Infusion Pump ◽

Hepatic Arterial Infusion ◽

Arterial Infusion ◽

Unresectable Metastatic Colorectal Cancer

Download Full-text